Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lobbestael

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Behavioural and Cognitive Psychotherapy|April 23, 2020
A cognitive behavioural group therapy for bipolar disorder using daily mood monitoringH T Henken, R W Kupka, S Draisma, et al.
Journal of Medicinal Chemistry|October 30, 1992
Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptakeM R Pavia, S J Lobbestael, D Nugiel, et al.
Alzheimer Disease and Associated Disorders|July 3, 1998
Safety of tacrine: clinical trials, treatment IND, and postmarketing experienceS I Gracon, M J Knapp, W G Berghoff, et al.
Quality & Safety in Health Care|June 5, 2007
What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary careM L van Driel, S Coenen, K Dirven, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Journal of Medicinal Chemistry|December 1, 1985
Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agentsL D Wise, I C Pattison, D E Butler, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Behavioural and Cognitive Psychotherapy|April 23, 2020
A cognitive behavioural group therapy for bipolar disorder using daily mood monitoringH T Henken, R W Kupka, S Draisma, et al.
Journal of Medicinal Chemistry|October 30, 1992
Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptakeM R Pavia, S J Lobbestael, D Nugiel, et al.
Alzheimer Disease and Associated Disorders|July 3, 1998
Safety of tacrine: clinical trials, treatment IND, and postmarketing experienceS I Gracon, M J Knapp, W G Berghoff, et al.
Quality & Safety in Health Care|June 5, 2007
What is the role of quality circles in strategies to optimise antibiotic prescribing? A pragmatic cluster-randomised controlled trial in primary careM L van Driel, S Coenen, K Dirven, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Journal of Medicinal Chemistry|December 1, 1985
Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agentsL D Wise, I C Pattison, D E Butler, et al.
Pageof 2